Clinical Trials Logo

Acquired Thrombotic Thrombocytopenic Purpura (aTTP) clinical trials

View clinical trials related to Acquired Thrombotic Thrombocytopenic Purpura (aTTP).

Filter by:
  • None
  • Page 1

NCT ID: NCT03922308 Recruiting - Clinical trials for Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

SOAR-HI
Start date: October 9, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of rADAMTS-13 (SHP655) administered in addition to standard of care (SoC) treatment of acquired thrombotic thrombocytopenic purpura (aTTP) participants.